SARS-CoV2 Testing: The Limit of Detection Matters
Top Cited Papers
Open Access
- 4 June 2020
- preprint content
- Published by Cold Spring Harbor Laboratory
Abstract
Resolving the COVID-19 pandemic requires diagnostic testing to determine which individuals are infected and which are not. The current gold standard is to perform RT-PCR on nasopharyngeal samples. Best-in-class assays demonstrate a limit of detection (LoD) of ~100 copies of viral RNA per milliliter of transport media. However, LoDs of currently approved assays vary over 10,000-fold. Assays with higher LoDs will miss more infected patients, resulting in more false negatives. However, the false-negative rate for a given LoD remains unknown. Here we address this question using over 27,500 test results for patients from across our healthcare network tested using the Abbott RealTime SARS-CoV-2 EUA. These results suggest that each 10-fold increase in LoD is expected to increase the false negative rate by 13%, missing an additional one in eight infected patients. The highest LoDs on the market will miss a majority of infected patients, with false negative rates as high as 70%. These results suggest that choice of assay has meaningful clinical and epidemiological consequences. The limit of detection matters.Keywords
This publication has 11 references indexed in Scilit:
- Open Development and Clinical Validation of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing BottleneckJournal of Clinical Microbiology, 2020
- Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Large-Scale, In-House Production of Viral Transport Media To Support SARS-CoV-2 PCR Testing in a Multihospital Health Care Network during the COVID-19 PandemicJournal of Clinical Microbiology, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJama-Journal Of The American Medical Association, 2020
- Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction A Systematic Review and Meta-analysisAnnals of Internal Medicine, 2017
- Performance of the Quidel Sofia rapid influenza diagnostic test during the 2012–2013 and 2013–2014 influenza seasonsInfluenza and Other Respiratory Viruses, 2016
- Sensitivity of the Quidel Sofia Fluorescent Immunoassay Compared With 2 Nucleic Acid Assays and Viral Culture to Detect Pandemic Influenza A(H1N1)pdm09Laboratory Medicine, 2015
- Enhanced analysis of real-time PCR data by using a variable efficiency model: FPK-PCRNucleic Acids Research, 2011
- Real-time PCR quantification using a variable reaction efficiency modelAnalytical Biochemistry, 2008
- A new method for robust quantitative and qualitative analysis of real-time PCRNucleic Acids Research, 2008